Novel monogenic diabetes mutations in the P2 promoter of the HNF4A gene are associated with impaired function in vitro.

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{4c49fd226a234cf287460a95c6f85b43,

title = "Novel monogenic diabetes mutations in the P2 promoter of the HNF4A gene are associated with impaired function in vitro.",

author = "A Wirsing and KA Johnstone and LW Harries and S Ellard and GU Ryffel and J Stanik and D Gasperikova and I Klimes and R Murphy",

year = "2010",

month = jun,

language = "English",

volume = "27",

pages = "631--635",

journal = "Diabetic Medicine",

issn = "0742-3071",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "6",

}

TY - JOUR

T1 - Novel monogenic diabetes mutations in the P2 promoter of the HNF4A gene are associated with impaired function in vitro.

AU - Wirsing, A

AU - Johnstone, KA

AU - Harries, LW

AU - Ellard, S

AU - Ryffel, GU

AU - Stanik, J

AU - Gasperikova, D

AU - Klimes, I

AU - Murphy, R

PY - 2010/6

Y1 - 2010/6

M3 - Article

SN - 0742-3071

VL - 27

SP - 631

EP - 635

JO - Diabetic Medicine

JF - Diabetic Medicine

IS - 6

ER -